The serological studies were used to test serum samples from human cancer patients and from persons with potential occupational exposure to BLV, among others, for evidence of BLV antibodies. All these studies are critically reviewed. It is concluded that there is no epidemiological or serological evidence from human studies to indicate that BLV can infect man. 